Benitec Biopharma appoints interim CEO

Company News

Benitec Biopharma Limited (ASX:BLT) has announced that Dr Peter French will step down as Managing Director and CEO of the company. 
Mr Greg West, Benitec’s Chief Financial Officer and Company Secretary has been appointed as the interim CEO. 
The company says it has commenced a global search for a new CEO and its intended the new CEO will be based in the United States. 
This is in line with Benitec’s goal to establish a stronger team in the US following its Nasdaq listing in August.
Benitec Biopharma reported a net loss of $11.5 million at 30 June 2015. 

Are you a 708 sophisticated investor?

If you are a sophisticated investor as defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

We can alert you to wholesale investment opportunities not available to regular investors.

Please subscribe if you would like to be alerted to these types of opportunities.